nach oben

International Journal of Mental Health and Addiction

Erschienen in:

08.01.2021 | Original Article

Size Estimation of People Who Inject Drugs and Their Geographical Distribution in Dogonbadan, Iran, During 2018: a Mapping Method

verfasst von: Sayed Hassan Faghihi, Nima Ghalekhani, Parvin Afsar Kazerooni, Maryam Nasirian

Erschienen in: International Journal of Mental Health and Addiction | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

The aim of this cross-sectional study was investigation of geographical distribution and size estimation of people who inject drugs (PWIDs) in Dogonbadan, Iran, in 2018 using geographical mapping method. Data was obtained through interviewing primary and secondary key informants as well as field team observations. Population size was estimated by median in Stata software (version 14). GIS software (version 10.6.1) was used to prepare the density and distribution maps of the hotspots. We identified 52 hotspots of drug users; injection of drugs occurred in 31 of the hotspots. The prevalence of injecting drugs was 232.4 per 100,000 adults, while it was 21.9 and 441.8 among females and males, respectively. A large number of identified hotspots are not covered by harm reduction services. Increasing outreach teams, equipping of harm reduction centers, and moving them to the nearest location to hotspots are suggested.

Azhdar, F., Esmaeilnasab, N., Moradi, G., Roshani, D., Ghaderi, E., & Nori, B. (2017). Estimation of intravenous drug users’ population in Kermanshah City, west of Iran in 2016 using capture-recapture method. Journal of Research in Health Sciences, 17(3). Retrieved from http://jrhs.umsha.ac.ir/index.php/JRHS/article/view/3418. Accessed 22 May 2019.

Chen, P., & Jacobson, K. C. (2012). Developmental trajectories of substance use from early adolescence to young adulthood: gender and racial/ethnic differences. The Journal of Adolescent Health, 50(2), 154–163. https://doi.org/10.1016/j.jadohealth.2011.05.013.CrossRefPubMed

Emmanuel, F., Blanchard, J., Zaheer, H. A., Reza, T., & Holte-McKenzie, M. (2010). The HIV/AIDS surveillance project mapping approach: an innovative approach for mapping and size estimation for groups at a higher risk of HIV in Pakistan. AIDS, 24, S77–S84. https://doi.org/10.1097/01.aids.0000386737.25296.c4.CrossRefPubMed

Ferguson, C. J., & Meehan, D. J. E. P. (2011). With friends like these …: peer delinquency influences across age cohorts on smoking, alcohol and illegal substance use. European Psychiatry, 26(1), 6–12. https://doi.org/10.1016/j.eurpsy.2010.09.002.CrossRefPubMed

Fizolahi, A., Danesh, P., Heidari, S., Sarokhani, M., & Sayehmiri, K. (2015). Estimation of number of addicts to drug abuse addicts by using capture-recapture method in Ilam City. Journal of Ilam University of Medical Sciences, 23(2), 120–124 Retrieved from http://sjimu.medilam.ac.ir/article-1-1671-en.html. Accessed 22 May 2019.

Ghasemian, R., Najafi, N., & Amirkhanloo, K. (2011). The study of infections due to injection drug abuse in the injecting drug users hospitalized at Imam Khomeini Hospital in Sari and Razi Hospital in Ghaemshahr in 2007-2009. Journal of Mazandaran University of Medical Sciences, 21(83), 9–15 Retrieved from http://jmums.mazums.ac.ir/article-1-684-fa.html. Accessed 22 May 2019.

JafariKhounigh, A., Haghdoost, A. A., SalariLak, S., Zeinalzadeh, A. H., Yousefi-Farkhad, R., Mohammadzadeh, M., & Holakouie-Naieni, K. (2014). Size estimation of most-at-risk groups of HIV/AIDS using network scale-up in Tabriz, Iran. Journal of Clinical Research & Governance, 3(1), 21–26. https://doi.org/10.13183/jcrg.v3i1.80.CrossRef

Javadi, A., Ataei, B., Yaran, M., Nokhodian, Z., Kassaian, N., Tayeri, K., et al. (2013). Prevalence of HIV infection and related risk factors in Isfahan drop in centers. Pakistan Journal of Medical Sciences, 29(1), 346–350. https://doi.org/10.12669/pjms.291(Suppl).3531.CrossRef

Khajehkazemi, R., Osooli, M., Sajadi, L., Karamouzian, M., Sedaghat, A., Fahimfar, N., Safaie, A., Mostafavi, E., & Haghdoost, A.-A. (2013). HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sexually Transmitted Infections, 89(Suppl 3), 29–32. https://doi.org/10.1136/sextrans-2013-051204.CrossRef

Khorshidi, A., Moradi, A., Shakiba, M., & Rahmani, K. (2015). Estimating the prevalence of drug abuse in Ilam using capture-recapture method. Journal of Mazandaran University of Medical Sciences, 25(124), 194–199.

Lotfi, Z., Gheirati, E., Tajik, F., Tavakoli, Z., Mahmoodi, M., & Holakouie Naieni, K. (2016). Estimation of the population of drug abusers using the network expansion method for assessment of the community in the Golhesar Village, Tehran. Journal of School of Public Health and Institute of Public Health Research, 14(3), 29–43 Retrieved from http://sjsph.tums.ac.ir/article-1-5407-en.html. Accessed 22 May 2019.

Modelling in Health Research Center, Regional Knowledge Hub and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University Of Medical Sciences, Kerman. Iran (2014). Estimating the size of drug and alcohol user populations and high-risk sexual groups in Iran. 2015,1–96 [Unpublished data].

Mohammad, K., Farahani, F. K. A., Mohammadi, M. R., Alikhani, S., Zare, M., Tehrani, F., & Ghanbari, H. (2007). Sexual risk-taking behaviors among boys aged 15–18 years in Tehran. The Journal of Adolescent Health, 41(4), 407–414. https://doi.org/10.1016/j.jadohealth.2007.05.003.CrossRefPubMed

Ministry of Health and Medical Education of Iran.(2014). Fourth Largest National Stratagem of HIV Infection in the Islamic Republic of Iran.4,1-379 Retrieved from http://port.health.gov.ir/mfdc/hiv/default.aspx. Accessed 22 May 2019.

The Ministry of Health and Medical Education of Iran.(2018). Reporting registered HIV infections in the Islamic Republic of Iran. 2018(4),1–7 Retrieved from Tehran: http://port.health.gov.ir/mfdc/hiv/default.aspx. Accessed 22 May 2019.

National Organization for Civil Registration of Iran .(2015). Population census and housing Islamic Republic Iran. 2016,1–53. Retrieved from Tehran: https://www.amar.org.ir/Portals/0/census/1395/results/ch_nsonvm_95.pdf. Accessed 22 May 2019.

Ndayongeje, J., Msami, A., Laurent, Y. I., Mwankemwa, S., Makumbuli, M., Ngonyani, A. M., et al. (2018). Illicit drug users in the Tanzanian hinterland: population size estimation through key informant-driven hot spot mapping. AIDS and Behavior, 22, 1–6. https://doi.org/10.1007/s10461-018-2057-x.CrossRef

Nguyen, T., Nguyen, L. T., Pham, M. D., Vu, H. H., & Mulvey, K. P. (2012). Methadone maintenance therapy in Vietnam: an overview and scaling-up plan. Advances in Preventive Medicine, 2012, 1–5. https://doi.org/10.1155/2012/732484.CrossRef

Nikfarjam, A., Shokoohi, M., Shahesmaeili, A., Haghdoost, A. A., Baneshi, M. R., Haji-Maghsoudi, S., Rastegari, A., Nasehi, A. A., Memaryan, N., & Tarjoman, T. (2016). National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. The International Journal on Drug Policy, 31, 147–152. https://doi.org/10.1016/j.drugpo.2016.01.013.CrossRefPubMed

Pathack, A., Saumtally, A., Soobhany, S., Comins, C. A., Kinoo, S. A., & Emmanuel, F. (2018). Programmatic mapping to determine the size and dynamics of sex work and injecting drug use in Mauritius. African Journal of AIDS Research, 17(2), 1–7. https://doi.org/10.2989/16085906.2018.1462216.CrossRef

Razani, N., Mohraz, M., Kheirandish, P., Malekinejad, M., Malekafzali, H., Mokri, A., McFarland, W., & Rutherford, G. (2007). HIV risk behavior among injection drug users in Tehran, Iran. Addiction, 102(9), 1472–1482. https://doi.org/10.1111/j.1360-0443.2007.01914.x.CrossRefPubMed

Razzaghi, E., Rahimi Movaghar, A., Mohammad, K., & Hosseini, M. (2004). A qualitative study of risky sexual behavior in injecting drug users in Tehran. Journal of School of Public Health and Institute of Public Health Research, 2(2), 1–10 Retrieved from http://sjsph.tums.ac.ir/article-1-264-en.html. Accessed 22 May 2019.

Regional Knowledge Hub, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University Of Medical Sciences, Kerman. Iran, Ministry of Health and Medical Education of Iran (2018). Executive protocol Mapping And Size Estimation of key Population In Iran 2(1)–86[In Persian].

Sarrami, H., Ghorbani, M., & Minooei, M. (2013). Survey of four decades of addiction prevalence researches in Iran. Research on Addiction, 7, 29–52 Retrieved from http://etiadpajohi.ir/article-1-286-en.html. Accessed 22 May 2019.

Shokoohi, M., Baneshi, M. R., & Haghdoost, A. A. (2010). Estimation of the active network size of Kermanian males. Addiction and Health, 2(3–4), 81–88.PubMedPubMedCentral

Shokoohi, M., Baneshi, M. R., & Haghdoost, A.-A. (2012). Size estimation of groups at high risk of HIV/AIDS using network scale up in Kerman, Iran. International Journal of Preventive Medicine, 3(7), 471–476.PubMedPubMedCentral

Somi, M., Noorabadi, G., Ramazani, R., Azimian, F., & Shakib Far, F. (2017). Prevention, control and treatment of hepatitis in Iran. 2018,1–86. Retrieved from http://www.health.gov.ir/mfdc/hd/SitePages/Home.aspx [In Persian]. Accessed 22 May 2019.

Joint United Nations Programme on HIV/AIDS (UNAIDS) (2017). Ending AIDS progress towards the 90–90–90 targets. 2017,1-198. Retrieved from https://www.unaids.org/en/resources/documents/2017/20170720_Global_AIDS_update_2017. Accessed 22 May 2019.

United Nation Office on Drugs and Crime (2018). Global overview of drug demand and supply. 2018,1–64. Retrieved from United Nations https://www.unodc.org/wdr2018. Accessed 22 May 2019.

Zamani, S., Vazirian, M., Nassirimanesh, B., Razzaghi, E. M., Ono-Kihara, M., Ravari, S. M., et al. (2010). Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS and Behavior, 14(4), 885–890. https://doi.org/10.1007/s10461-008-9404-2.CrossRefPubMed

Titel: Size Estimation of People Who Inject Drugs and Their Geographical Distribution in Dogonbadan, Iran, During 2018: a Mapping Method
verfasst von: Sayed Hassan Faghihi
Nima Ghalekhani
Parvin Afsar Kazerooni
Maryam Nasirian
Publikationsdatum: 08.01.2021
Verlag: Springer US
Erschienen in: International Journal of Mental Health and Addiction / Ausgabe 2/2022
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882
DOI: https://doi.org/10.1007/s11469-020-00439-1

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2022

Psychological Impact of COVID-19 Duties During Lockdown on Police Personnel and Their Perception About the Behavior of the People: an Exploratory Study from India

Needle Pulmonary Embolism in an Intravenous Drug User: a Case Report

Succumbing to the COVID-19 Pandemic—Healthcare Workers Not Satisfied and Intend to Leave Their Jobs

Personalising Outcome Measurement in Substance Misuse Treatment: the Feasibility and Psychometrics of Two Individualised Outcome Measures

Barriers and Facilitators of Addiction Treatment: a Qualitative Study

Adaptation and Validation of the Brazilian Version of the Fear of COVID-19 Scale